RON-BIN HSULin F.-Y.2020-03-102020-03-1020080741-5214https://www.scopus.com/inward/record.uri?eid=2-s2.0-38649139888&doi=10.1016%2fj.jvs.2007.10.017&partnerID=40&md5=9ecb976bb82c5d661ca7c441f9309a31https://scholars.lib.ntu.edu.tw/handle/123456789/474946[SDGs]SDG3ceftriaxone; adult; aged; aorta arch; article; bacterium isolate; clinical article; controlled study; descending aorta; female; human; infected aneurysm; infection; male; medical record; microbiological examination; mortality; Mycobacterium tuberculosis; outcome assessment; pathogenesis; priority journal; Salmonella; Staphylococcus aureus; thoracic aorta aneurysm; Aged; Aged, 80 and over; Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Thoracic; Blood Vessel Prosthesis Implantation; Debridement; Female; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Research Design; Retrospective Studies; Time Factors; Treatment OutcomeInfected aneurysm of the thoracic aortajournal article10.1016/j.jvs.2007.10.017182417482-s2.0-38649139888